Safety outcomes from monarchE: Phase 3 study of abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER-2-, node-positive, high risk, early breast cancer

Rugo H., O'Shaughnessy J., Song C., Broom R., Gumus M. , Yamashita T., ...More

BREAST, vol.56, 2021 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Abstract
  • Volume: 56
  • Publication Date: 2021
  • Title of Journal : BREAST